The CEO of Turing Pharmaceuticals is defending his decision to raise the price of the life-saving drug Daraprim from $13.50 to $750 a tablet. Outrage over his decision has spread to the campaign trial and triggered instability on Wall Street. New York Times Reporter Andrew Pollack and Infectious Disease Specialist, Dr. Frank Esper join NewsNation.Sept. 22, 2015
UP NEXT
Capt. ‘Sully’ on Boeing’s aviation safety: ‘They have lost their way’
06:08
Trump pledges to combat crime while attending wake for NYPD officer
02:08
Debris field from Baltimore bridge collapse is 'very dangerous' for divers: Tiburon Subsea CEO
05:34
It's Opening Day! Major League Baseball season kicks off today
02:56
'We Were the Lucky Ones' follows a family's escape from the Holocaust
09:57
BREAKING: Sam Bankman-Fried sentenced to 25 years in prison